TWO SIGMA INVESTMENTS, LP - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 62 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q1 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2022$40,000
-50.6%
161,483
+3.6%
0.00%–
Q2 2022$81,000
+3.8%
155,815
+307.9%
0.00%–
Q1 2022$78,000
-88.2%
38,197
-75.9%
0.00%
-100.0%
Q4 2021$660,000
+256.8%
158,214
+695.8%
0.00%–
Q3 2021$185,000–19,882–0.00%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q1 2022
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders